NASDAQ
Citius Pharmaceuticals, Inc. (CTXR) has a current ratio of 0.62x as of Monday, May 25, 2026. This represents a 92.78% decrease compared to its 12-month average of 8.62x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.